Exciting news! CTIBIOTECH is proud to announce our participation in the EACR Conference on Liquid Biopsies in Lyon, France, from November 12th to 14th, 2024! 🇫🇷
Join us at this important event to meet our experts, Mrs. Nelly Dubrulle, International Business Developer, and Mr. Clément Milet Milet, Laboratory and Quality Director. They will be on hand to showcase our innovative CTIPharma™ technologies for immuno-oncology and cancer research.
CTIPharma™ provides a comprehensive range of cancer hashtag#bioassays and biological specimens to support pre-clinical research in oncology, including:
- Original patient-derived tumors, liquid biopsies, and dissociated tumor cells
- Patient-derived xenograft (PDX) tumors and cells
- Characterized primary cancer cells and cancer-associated fibroblasts
- 3D bioprinted Microtumors: industrial-scale production of advanced 3D human tumoroid plates
- Purified immune cells and stem cells for immuno-oncology experiments, including neutrophils, T-cells, B-cells, dendritic cells, NK cells, and more
This conference is a fantastic opportunity to explore the latest advancements in liquid biopsy technologies and engage with leading experts in the field.
Discover our full catalogue and latest inventory at https://independentbiobank.com/.
We look forward to connecting with fellow researchers and industry leaders as we advance cancer research together!
